A former official with the Food and Drug Administration (FDA) says he’d be “shocked” if marijuana is not moved to schedule III prior to the 2024 presidential election.
Howard Sklamberg, former FDA Deputy Commissioner for global regulatory operations / compliance, says he would be “really shocked if it took the DEA longer than the second quarter of next year to come up with its final rule. Even when I was at FDA, we knew that important regulations that you wanted to get done in an election year, you want to get done by the summer before.”
Sklamberg, who chaired the FDA’s Marijauna Working Group for several years, says he believes the DEA will approve the Department of Health’s recommendation to move marijuana to schedule III, which would effectively legalize it for prescription use across the United States.
Continue reading